you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Dec 08, 16:00
4568.20 39.70 (0.88%)
Volume
AVERAGE VOLUME
5-Day
13,730
10-Day
16,912
30-Day
14,241
23,566
  • Prev. Close

    4528.50

  • Open Price

    4511.10

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 08, 15:59
4570.70 50.00 (1.11%)
Volume
AVERAGE VOLUME
5-Day
401,143
10-Day
544,063
30-Day
429,255
195,856
  • Prev. Close

    4520.70

  • Open Price

    4527.25

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Quarterly Results of Dr Reddys Laboratories (in Rs. Cr.) Sep '21 Jun '21 Mar '21 Dec '20 Sep '20  
Net Sales/Income from operations 3,823.40 3,433.50 3,350.70 3,408.20 3,333.60  
Other Operating Income -- -- -- -- 12.20  
Total Income From Operations 3,823.40 3,433.50 3,350.70 3,408.20 3,345.80  
EXPENDITURE  
Consumption of Raw Materials 673.20 870.70 816.30 845.30 816.50  
Purchase of Traded Goods 656.20 623.50 326.60 321.10 304.30  
Increase/Decrease in Stocks 25.20 -302.50 20.80 -87.70 -135.80  
Power & Fuel -- -- -- -- --  
Employees Cost 635.20 586.50 545.60 571.50 608.00  
depreciat 206.60 197.10 210.70 212.40 214.20  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- 936.20  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 1,085.30 1,093.40 1,038.50 984.00 --  
P/L Before Other Inc. , Int., Excpt. Items & Tax 541.70 364.80 392.20 561.60 602.40  
Other Income 118.10 186.20 81.60 62.80 26.60  
P/L Before Int., Excpt. Items & Tax 659.80 551.00 473.80 624.40 629.00  
Interest 11.10 6.50 16.90 6.50 9.30  
P/L Before Exceptional Items & Tax 648.70 544.50 456.90 617.90 619.70  
Exceptional Items -- -- -- -- --  
P/L Before Tax 648.70 544.50 456.90 617.90 619.70  
Tax 199.70 131.10 145.40 174.20 138.70  
P/L After Tax from Ordinary Activities 449.00 413.40 311.50 443.70 481.00  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 449.00 413.40 311.50 443.70 481.00  
Equity Share Capital 83.20 83.20 83.20 83.10 83.10  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 27.07 24.94 18.78 26.74 29.00  
Diluted EPS 27.00 24.87 18.73 26.66 28.92  
EPS After Extra Ordinary  
Basic EPS. 27.07 24.94 18.78 26.74 29.00  
Diluted EPS. 27.00 24.87 18.73 26.66 28.92  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs